Glycerol phenylbutyrate and Ranibizumab ophthalmic
Determining the interaction of Glycerol phenylbutyrate and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycerol phenylbutyrate
Brand name: Ravicti
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycerol phenylbutyrate-Ranitidine
- Glycerol phenylbutyrate-Ranitidine Capsule
- Glycerol phenylbutyrate-Ranitidine Hydrochloride
- Glycerol phenylbutyrate-Ranitidine Injection
- Glycerol phenylbutyrate-Ranitidine Suspension
- Glycerol phenylbutyrate-Ranitidine Syrup
- Ranibizumab ophthalmic-GlycoLax
- Ranibizumab ophthalmic-Glycophos
- Ranibizumab ophthalmic-Glycophos Injection
- Ranibizumab ophthalmic-Glycopyrrolate
- Ranibizumab ophthalmic-Glycopyrrolate (Oral Inhalation)
- Ranibizumab ophthalmic-Glycopyrrolate (Systemic)